Ceftriaxone-Induced Pancytopenia: A Case Report

QR Code

Ceftriaxone-Induced Pancytopenia: A Case Report

<b>Background:</b> Cephalosporins are considered safe antibiotics. However, serious hematological abnormalities may occur, although rarely, after their therapeutic use. <b>Case Presentation:</b> We present a case of pancytopenia in a 72-year-old female patient treated with ce...

Full description

Saved in:

Bibliographic Details
Main Authors:	Edin Karisik, Zorica Stanojevic-Ristic, Marija Jevtic, Julijana Rasic, Miljana Maric, Milica Popovic
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Hematology Reports
Subjects:	pancytopenia ceftriaxone idiosyncrasy filgrastim antibiotics
Online Access:	https://www.mdpi.com/2038-8330/17/3/30
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A case of hypopituitarism with pancytopenia cured by corticosteroid and thyroid hormone replacement therapy
by: Violeta Mladenovic, et al.
Published: (2025-07-01)

Influence of the Parameter «The Rate of Administration» During the Test «Abnormal Toxicity» on Quality Control of Ceftriaxonе an Antibiotic of the Cephalosporin Group
by: M. V. Sharoykina, et al.
Published: (2020-05-01)

CASE REPORT: PANCYTOPENIA IN SEVERE MALARIA WITH SUSPECTED HEMOPHAGOCYTIC SYNDROME AT ATAMBUA HOSPITAL
by: Krisdianto Putra Lainy, et al.
Published: (2023-03-01)

PERBANDINGAN PEMBERIAN ANTIBIOTIK PROFILAKSIS CEFTRIAXON DAN NON-CEFTRIAXON TERHADAP KEJADIAN SURGICAL SITE INFECTION PASCA KOLESISTEKTOMI
by: Alexander Lim, et al.
Published: (2017-06-01)

A Case of Drug-Induced Liver Injury Secondary to Ceftriaxone
by: Rupesh Ramtel
Published: (2025-06-01)

PERBANDINGAN PEMAKAIAN CEFTRIAXONE TERHADAP INFEKSI LUKA OPERASI PADA PASIEN APENDISITIS AKUT NON KOMPLIKATA YANG DILAKUKAN LAPARATOMI DAN LAPARASKOPI APENDIKTOMI
by: Ilham Farizal, et al.
Published: (2016-11-01)

A Case of Hemophagocytic Lymphohistiocytosis During Immune Checkpoint Inhibitor Treatment for Metastatic Renal Cell Carcinoma, Complicated by Pancytopenia Attributed to Cytomegalovirus Infection
by: Tomoko Honda, et al.
Published: (2025-07-01)

Peripheral nerve injury recovery enhanced by ceftriaxone: a preclinical investigation
by: Berkin Gunar, et al.
Published: (2025-07-01)

Characterizing pancytopenia in a large Asian cohort of people living with HIV: A 23-year nested case-control study
by: Xiangyi Shen, et al.
Published: (2025-08-01)

Impact of Liposomes and Ceftriaxone-Entrapped Liposomes on Skin Wound Healing in Rats
by: N. L. Kurilko, et al.
Published: (2020-05-01)

Risk of Pseudogallstones and Biliary Complications in Rehabilitation Patients Administered Ceftriaxone: A Retrospective Study
by: Hidehiro Kamezaki, et al.
Published: (2025-07-01)

Acute necrotizing calculous cholecystitis after treatment with ceftriaxone in an elderly patient: a case report
by: Tsunehiko Shigemori, et al.
Published: (2022-05-01)

Artificial Intelligence (AI) and Drug-Induced and Idiosyncratic Cytopenia: The Role of AI in Prevention, Prediction, and Patient Participation
by: Emmanuel Andrès, et al.
Published: (2025-04-01)

Treatment of infective endocarditis caused by Enterococcus faecalis with a combination of penicillin G and ceftriaxone: a case report and literature review
by: Li Jiang, et al.
Published: (2025-07-01)

Comparative outcomes of Piperacillin-Tazobactam versus Ceftriaxone in managing spontaneous bacterial peritonitis in cirrhotic patients: An observational study
by: Azhar Hussain, et al.
Published: (2025-06-01)

Rapid Determination of Ceftriaxone in Mixed Saliva of Practically Healthy Subjects and Patients with Infectious and Somatic Pathologies
by: E. G. Kulapina, et al.
Published: (2020-05-01)

Gaucher Disease: A First Reported Adult Case in Indonesia
by: Ardhi Rahman Ahani, et al.
Published: (2024-04-01)

Outbreak of Ceftriaxone-Resistant Salmonella enterica Serovar Typhi, Bangladesh, 2024
by: Yogesh Hooda, et al.
Published: (2025-07-01)

Risks of Oral Methotrexate Administration in Outpatients
by: Maria Ganeva, et al.
Published: (2014-11-01)

Factors Associated with Absolute Neutrophil Count Dynamics and Docetaxel-Adryamicin-Cyclophosphamide (TAC) Chemotherapy Induced Neutropenia During Extended Filgrastim Administration in Breast Cancer Patients
by: Ami Ashariati, et al.
Published: (2022-09-01)

Efficacy of filgrastim therapy for patients with progressive multifocal leukoencephalopathy: Two case reports
by: Hanako Aoki, et al.
Published: (2025-09-01)

Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation
by: M. V. Zhuravleva, et al.
Published: (2024-02-01)

Erythema multiforme secondary to filgrastim in a case of pemphigus vulgaris
by: Prachi Bhandare, et al.
Published: (2025-01-01)

Brucella-associated hemophagocytic syndrome: case report of a potentially life-threatening condition and literature review
by: Limei Shi, et al.
Published: (2025-07-01)

The Underestimated Threat—Mycobacterium Genavense Infection: A Case Report
by: Jannik Sonnenberg, et al.
Published: (2025-06-01)

Lipegfilgrastim in patients with chemotherapy-induced neutropenia
by: G. D. Petrova, et al.
Published: (2015-12-01)

A Clinical Case of Aplastic Anemia After COVID-19 Infection
by: G. Sh. Safuanova, et al.
Published: (2021-11-01)

Standing on the shoulders of imperfect humans: Adjunctive therapy for Enterococcus faecalis infective endocarditis
by: Connor Prosty, et al.
Published: (2025-09-01)

Evaluation of the Efficacy and Safety of Initial Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Middle-Aged People
by: T. V. Alexandrova, et al.
Published: (2022-07-01)

Metal–Oxide Photocatalysts with Heterojunctions for Ceftriaxone Removal from Water Matrices
by: Roxana Ioana Matei (Brazdis), et al.
Published: (2023-12-01)

Recommendations for the Contents of the “Peptide Mapping” Part of a Product Specification File
by: O. A. Vaganova
Published: (2021-12-01)

Idiosyncratic Drug-Induced Liver Injury: From Pathogenesis to Risk Reduction
by: I. A. Mazerkina
Published: (2023-06-01)

The Possibility to Use Medications Purchased at the Expense of a Patient in Intensive Care Units of Healthcare Institutions
by: O. Yu. Aleksandrova, et al.
Published: (2017-09-01)

STUDY OF WOUND HEALING ACTIVITY OF A MEDICINAL PRODUCT «GMDP LYOPHILIZATE FOR PREPARATION OF SOLUTION FOR INJECTION» PRODUCTION JSC «PEPTEK» (RUSSIA) IN THE SCHEMES OF COMBINED ANTIBIOTIC-IMMUNE THERAPY ON THE MODEL OF INFECTED SKIN WOUNDS AND SOFT TISSUES IN RATS
by: M. S. Zhuravleva, et al.
Published: (2019-01-01)

Prevention of neutropenia as an important factor in successful chemotherapy for head and neck cancer
by: L. G. Babicheva, et al.
Published: (2021-11-01)

Oral and parenteral treatment with a third-generation cephalosporin promotes the proliferation of diverse ESBL-producing Escherichia coli in the chicken intestinal tract
by: Lázaro López, et al.
Published: (2025-07-01)

RATIONAL USE OF 3rd GENERATION CEPHALOSPORINS IN TERTIARY CARE HOSPITALS: A CONCURRENT DUR
Published: (2022-03-01)

Extensively Drug-Resistant Neisseria gonorrhoeae Strain, Canada
by: Brigitte Lefebvre, et al.
Published: (2025-07-01)

Toxic Reactions in Probable and Confirmed Methotrexate Overdose in Rheumatology Patients: A Case Series
by: S. A. Doktorova, et al.
Published: (2024-12-01)

Pancytopenia in epidemic dropsy: a case report
by: Ashish Gautam, et al.
Published: (2025-04-01)